Ipsen

Lobbying Organisation Ipsen

Date published 20 Jan, 2023

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Sep, 2022 to 31 Dec, 2022

Specific Details Meetings to discuss the EU Pharmaceutical Strategy review in 2022

Intended results A meeting with Minister and MEP

Name of person primarily responsible for lobbying on this activity IAN WEATHERHEAD

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

A meeting between the Tanaiste, Leo Varadkar, the IDA and Senior Executives of Ipsen and Frances Fitzgerald, Member of the European Parliament. Ipsen took the opportunity to discuss the EU pharmaceutical strategy and shared the latest data on Ireland’s performance when it comes to access to innovative medicines.

Letter (1)

Letter was sent to Leo Varadkar to follow-up on the meeting and to outline to main points of the conversation.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Leo Varadkar Minister (Department of Enterprise, Trade and Employment)

Frances Fitzgerald MEP (European Parliament)